Cover Image
市場調查報告書

鼻咽癌:全球臨床實驗檢討

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 146504
出版日期 內容資訊 英文 81 Pages
訂單完成後即時交付
價格
Back to Top
鼻咽癌:全球臨床實驗檢討 Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月27日 內容資訊: 英文 81 Pages
簡介

本報告提供全球主要地區的鼻咽癌治療藥臨床實驗數和受驗人數,各階段趨勢,再加上主要企業和機關,臨床實驗簡介等。

簡介

  • 鼻咽癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區前五名國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

參與鼻咽癌臨床實驗的主要企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Sanofi
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co., Inc.
    • Jiangsu Hengrui Medicine Co., Ltd.
    • ZonMw
    • Roche Hong Kong Limited
    • Lakewood-Amedex Inc.
    • C. H. Boehringer Sohn AG & Co. KG
    • Biotech Pharmaceuticals Co., Ltd.
  • 代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Sun Yat-sen University
    • Sun Yat-Sen University Cancer Center
    • Chinese University of Hong Kong
    • FUDAN University
    • Baylor College of Medicine
    • National University Hospital
    • European Organization for Research and Treatment of Cancer
    • The University of Hong Kong
    • University of Washington

5個代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2053CTIDB

GlobalData's clinical trial report, "Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasopharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nasopharyngeal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Nasopharyngeal Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Nasopharyngeal Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Nasopharyngeal Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Nasopharyngeal Cancer
    • Dec 16, 2011: Radiation Therapy Oncology Group Trial Results Show Bevacizumab Reduces Spread Of Nasopharyngeal Cancer
    • May 29, 2009: Cyclacel Reports Initial Phase 2 Seliciclib Data In Patients With Nasopharyngeal Carcinoma At 2009 Asco Annual Meeting
    • Mar 05, 2009: Cyclacel Announces Phase 1 Data Elucidating Pharmacodynamics & Mechanism Of Action Of Seliciclib In Nasopharyngeal Cancer
    • Aug 28, 2008: CYCLACEL Announces Recommendations Of Data Review Committee For Seliciclib Phase 2b Non-Small Cell Lung Cancer APPRAISE Trial
    • Jun 28, 2007: Cyclacel Pharmaceuticals Announces Results Of Phase II Seliciclib Combination Studies
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Jiangsu Hengrui Medicine Co., Ltd.
      • Clinical Trial Overview of Jiangsu Hengrui Medicine Co., Ltd.
      • ZonMw
      • Clinical Trial Overview of ZonMw
      • Roche Hong Kong Limited
      • Clinical Trial Overview of Roche Hong Kong Limited
      • Lakewood-Amedex Inc.
      • Clinical Trial Overview of Lakewood-Amedex Inc.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Biotech Pharmaceuticals Co., Ltd.
      • Clinical Trial Overview of Biotech Pharmaceuticals Co., Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • Sun Yat-Sen University Cancer Center
      • Clinical Trial Overview of Sun Yat-Sen University Cancer Center
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • FUDAN University
      • Clinical Trial Overview of FUDAN University
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • National University Hospital
      • Clinical Trial Overview of National University Hospital
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • The University of Hong Kong
      • Clinical Trial Overview of The University of Hong Kong
      • University of Washington
      • Clinical Trial Overview of University of Washington
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Nasopharyngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Nasopharyngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Nasopharyngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Nasopharyngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Nasopharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Jiangsu Hengrui Medicine Co., Ltd., 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Hong Kong Limited, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Lakewood-Amedex Inc., 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotech Pharmaceuticals Co., Ltd., 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-Sen University Cancer Center, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Hospital, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*

List of Figures

  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Nasopharyngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Nasopharyngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Nasopharyngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Nasopharyngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Nasopharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top